Abstract:To explore the relation between heparanase (HPA) and nm23-H1 in hepatocellular carcinoma (HCC), and judge whether they may be used as valuable markers in predicting postoperative metastasis and recurrence of HCC.Reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry (S-P method) were used to measure the expressions of the HPA mRNA and nm23-H1 protein in the primary tumor tissue and paracancer tissue of 33 cases of HCC. The paracancer tissues of 9 cases of benign liver tumor were used as normal controls. The results were analyzed in combination with the results of clinicopathological examination and follow-up.The expression of HPA gene was positive in 16 cases of primary tumor tissues of HCC with a positive rate of 48.5%, significantly higher than those in paracancer tissues of HCC cases and in normal controls (P < 0.01). The HPA expression was not related with the size of tumor, envelope formation, AFP level, HBsAg state and cirrhosis of liver. The positive rates of HPA mRNA in the group with high tendency to metastasis or recurrence and the group with metastasis or recurrence during follow-up were significantly higher than that in the group with low tendency to metastasis or recurrence group (P < 0.05) and that in the group without metastasis or recurrence (P < 0.01). The poorly differentiated tumor and tumor of TNM stage III-IV had higher positive rates of HPA gene expression than the well-mediate differentiated tumor and tumor of TNM stage I-II (P < 0.05). The positive expression rates of nm23-Hl protein in HCC tissue was significantly lower than that in corresponding non-cancerous or normal liver tissue (P < 0.05). nm23-Hl expression was not related with the size of tumor, envelope formation, AFP level, HBsAg state, cirrhosis of liver, Edmondson grade, and TNM stage (P > 0.05). The positive rate of nm23-Hl in the group with high tendency to metastasis and recurrence and in patients with metastasis or recurrence during follow-up was obviously higher than that in the group with low tendency to metastasis and recurrence (P = 0.018) and that in the patients without metastasis and recurrence (P = 0.024), but no significant difference was found between HPA positive and negative groups (P = 0.082). According to the results of follow-up, the rates of accuracy in predicting metastasis of positive HPA, negative nm23-H1 and combination of positive HPA with negative nm23-H1 were 78.6% (11/14), 68.8% (11/16) and 88.9% (8/9) respectively.Expression of HPA and/or nm23-Hl are related with metastasis and recurrence of HCC. Combining the expression rate of HPA with the expression rate of nm23-H1 may increase the accuracy in predicting HCC postoperative metastasis and recurrence.

High-level expression of periostin is closely related to metastatic potential and poor prognosis of hepatocellular carcinoma

High-level Expression of Periostin is Significantly Correlated with Tumour Angiogenesis and Poor Prognosis in Osteosarcoma.

Overexpression Of Periostin Is Significantly Correlated To The Tumor Angiogenesis And Poor Prognosis In Patients With Esophageal Squamous Cell Carcinoma

High-level Expression of Periostin is Significantly Correlated with Tumor Angiogenesis in Prostate Cancer.

Effects of Periostin on Hepatocellular Carcinoma Cells Invasion, Metastasis and Prognosis

High Preoparative Levels of Serum Periostin Are Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Hepatectomy.

High Expression of VEGF in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Prognostic Significance of Osteopontin in Hepatitis B Virus-Related Hepatocellular Carcinoma

High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma

The expression of PDGFRα in HCC and association with prognosis

The expression of OPN in hepatocellular carcinoma and their clinical significance

Protein tyrosine phosphatase non-receptor II: A possible biomarker of poor prognosis and mediator of immune evasion in hepatocellular carcinoma

The Expression and Clinical Significance of Periostin in Human Breast Cancer

Protein Expression Profiling of Vascular Endothelial Growth Factor and Its Receptors Identifies Subclasses of Hepatocellular Carcinoma and Predicts Survival

Overexpression of Periostin Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Overexpressed Pepsinogen C is Associated with Poor Prognosis in Human Hepatocellular Carcinoma: a Tissue Microarray Study

Expressions of PCNA and Hpa and Their Correlations with Prognosis of Patients with Hepatocellular Carcinoma

Peritumoral Neuropilin-1 and VEGF Receptor-2 Expression Increases Time to Recurrence in Hepatocellular Carcinoma Patients Undergoing Curative Hepatectomy.

High-level Expression of HOXB13 is Closely Associated with Tumor Angiogenesis and Poor Prognosis of Hepatocellular Carcinoma.

Relative Analysis of OPN and Its Related Signal Molecules in Hepatocellular Carcinoma

[The Expression and Significance of Heparanase and Nm23-H1 in Hepatocellular Carcinoma].